Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04579757
Title Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associated, PC-HOPE Tucson Arizona 85711 United States Details
City of Hope Duarte California 91010 United States Details
Rocky Mountain Cancer Centers Midtown Denver Colorado 80218 United States Details
Johns Hopkins University - Sibley Memorial Hospital Washington District of Columbia 20016 United States Details
Emory University - Winship Cancer Institute Atlanta Georgia 30322 United States Details
Holden Comprehensive Cancer Center, University of Iowa Iowa City Iowa 52242 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
University of Pennsylvania, Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 United States Details
Prisma Health - Upstate (ITOR) Greenville South Carolina 29605 United States Details
Sarah Cannon Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Texas Oncology, P.A. Fort Worth Texas 76104 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77079 United States Details
Texas Oncology, P.A. Tyler Texas 75702 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field